Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer
Brittany A Davidson, Angeles Alvarez Secord Division of Gynecologic Oncology, Duke Cancer Institute, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA Abstract: Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer. Recently, clinical trials h...
Saved in:
Main Authors: | Davidson BA (Author), Secord AA (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pazopanib for the treatment of soft-tissue sarcoma
by: Heudel P, et al.
Published: (2012) -
The detection, treatment, and biology of epithelial ovarian cancer
by: Gubbels Jennifer AA, et al.
Published: (2010) -
Phototoxic Reaction Induced by Pazopanib
by: Siriorn Udompanich, et al.
Published: (2018) -
Surgical Resection and Pazopanib Treatment for Recurrent Cardiac Angiosarcoma
by: Yuki Nakamura, et al.
Published: (2019) -
Treatment for recurrent epithelial ovarian cancer
by: Yiu-Tai Li, et al.
Published: (2021)